Hospital ventilation services

We are a specialist validation/verification testing team of experts for both standard and ultra-clean theatres. We are at the forefront of the battle to control airborne infection in hospitals in public and private sectors.

In our Healthcare Ventilation division, we employ highly qualified and highly experienced technical engineers, surveyors and managers supported by a skilled and committed administration team. 

The key tasks undertaken are airflow measurements, pressure cascades, particle counting, microbiological sampling, and auditing of air handling units all to fit in with your tight theatre schedules.

Our work ranges from single-theatre hospitals to hospitals with over 20 theatres and major operating suites. We already undertake microbiological and ventilation testing work for some of the UK’s leading hospital trusts.

We are one of a very small number of UK companies that undertake specialist ventilation assessments and we are respected industry experts in this field.
EVENTS
20 October
2021
In partnership with the ICBA

Particles and Health 2021

  • 20 October 2021
  • Running from the 20.10.21 to 21.10.21

IOM is proud to be sponsoring the Particles and Health conference, a two day event designed for regulators and researchers to:

  • Address scientific studies regarding human health effects of PSLTs. The value of human studies over animal studies-when human-exposed populations can be studied adequately- will be emphasized.
  • Review and discuss definition of PSLT’s proposed at Edinburgh workshop and published in 2020 in the Journal Inhalation Toxicology with attention to both similarities and differences among these substances.
  • Address translational toxicology challenges, including the appropriateness of rats as models for human lung pathogenesis (particularly lung cancer) in light of lung overload phenomena and species differences.
  • Serve as a platform to present current scientific information about PSLTs important for regulatory action.
  • Publication of pertinent conference presentations in the peer reviewed scientific literature will allow the presentations to live beyond the conference and subsequently be reviewed part of regulatory deliberations.
  • Establish an interdisciplinary setting for industry, academia and regulatory professionals to interact on an important topic. Such interaction can facilitate enhanced understanding of the science and appropriate classification, labelling and setting exposure limits, among others.
  • Recommend areas for further research regarding the significance of the rat as a model for translation toxicology. 
  • Review the biokinetics of inhaled nanoparticles and the potential for non-pulmonary effects.

For more information and tickets please visit the Particles and Health website here.

Event info
We're here to provide you with more information and answer any questions you may have. Contact